Case number 1:21-cv-01710
Galderma Laboratories L.P. et al v. Lupin Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 9, 2024 | 234 | ORDER of USCA as to 202 Notice of Appeal (Federal Circuit) filed by Galderma Laboratories L.P., TCD Royalty Sub LP. Decision of USCA: The motion for an injunction pending appeal is denied. The motion to expedite is granted to the extent provided in this order (see order for further details). (jfm) (Entered: 05/16/2024) (3) |
| Apr 22, 2024 | 233 | EXHIBIT re 191 Redacted Document by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A1-A300)(Haney, Megan) (Entered: 04/22/2024) (0) |
| Apr 19, 2024 | 223 | REDACTED VERSION of 213 Answering Brief in Opposition, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/19/2024) (26) |
| Apr 19, 2024 | 224 | REDACTED VERSION of 207 Answering Brief in Opposition, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/19/2024) (20) |
| Apr 19, 2024 | 225 | REDACTED VERSION of 214 Declaration by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/19/2024) (30) |
| Apr 19, 2024 | 226 | REDACTED VERSION of 215 Declaration by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/19/2024) (10) |
| Apr 19, 2024 | 227 | REDACTED VERSION of 204 Opening Brief in Support, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 228 | REDACTED VERSION of 216 Declaration,,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37)(Phillips, John) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 229 | REDACTED VERSION of 205 Declaration by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits A-K)(Tigan, Jeremy) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 230 | REDACTED VERSION of 209 Reply Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/19/2024) (15) |
| Apr 19, 2024 | 231 | REDACTED VERSION of 217 Reply Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/19/2024) (10) |
| Apr 19, 2024 | 232 | Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding the parties have no redactions to the Court's Opinion and Order (D.I. 218, 219). (Phillips, John) (Entered: 04/19/2024) (1) |
| Apr 12, 2024 | 221 | ORAL ORDER: The parties have until Friday, April 19, 2024, to submit redacted versions of the Opening Brief and Declarations (D.I. 204 , 205 ), Answering Briefs and Declarations (D.I. 207 , 213 , 214 , 215 , 216 ), Reply Briefs (D.I. 209 , 217 ), and the Opinion and Order (D.I. 218 , 219 ). I DENY AS MOOT the stipulation to extend time (D.I. 220 ). Signed by Judge Stephanos Bibas on 04/12/2024. (vfm) (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | 222 | REDACTED VERSION of 208 Letter by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/12/2024) (2) |
| Apr 11, 2024 | 218 | [UNSEALED] MEMORANDUM OPINION. Signed by Judge Stephanos Bibas on 4/11/2024. (rlr) (Entered: 04/11/2024) (8) |
| Apr 11, 2024 | 219 | [UNSEALED] ORDER denying 203 Emergency MOTION for Injunction and Temporary Restraining Order Pending Appeal. Signed by Judge Stephanos Bibas on 4/11/2024. (rlr) (Entered: 04/11/2024) (1) |
| Apr 11, 2024 | 220 | STIPULATION TO EXTEND TIME for Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP to submit redacted versions of their Opening Brief in Support of Emergency Motion for Injunction and supporting Declaration (D.I. 204-205) to April 12, 2024 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/11/2024) (1) |
| Apr 10, 2024 | 217 | [SEALED] Second REPLY BRIEF re 203 Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/10/2024) (0) |
| Apr 9, 2024 | 213 | [SEALED] ANSWERING BRIEF in Opposition re 203 Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion [UPDATED] filed by Lupin Inc., Lupin Limited.Reply Brief due date per Local Rules is 4/16/2024. (Phillips, John) (Entered: 04/09/2024) (0) |
| Apr 9, 2024 | 214 | [SEALED] DECLARATION re 213 Answering Brief in Opposition, Rebuttal Expert Declaration of Anthony M. Masztak by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/09/2024) (0) |
| Apr 9, 2024 | 215 | [SEALED] DECLARATION re 213 Answering Brief in Opposition, Declaration of Robert G. Hoffman by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 04/09/2024) (0) |
| Apr 9, 2024 | 216 | [SEALED] DECLARATION re 213 Answering Brief in Opposition, Declaration of Katie Boda by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37)(Phillips, John) (Entered: 04/09/2024) (0) |
| Apr 8, 2024 | 209 | [SEALED] REPLY BRIEF re 203 Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/08/2024) (0) |
| Apr 8, 2024 | 210 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Response to Lupin's Letter - re 208 Letter. (Tigan, Jeremy) (Entered: 04/08/2024) (0) |
| Apr 8, 2024 | 211 | ORAL ORDER: I ORDER Galderma to inform Lupin of any objections to its expert, Mr. Masztak, receiving Galderma's confidential information by 12:00 p.m. on Monday, April 8. See D.I. 208 . Lupin SHALL then file an updated answering brief by 5:00 p.m. on Tuesday, April 9. Galderma MAY then file a reply brief by Wednesday, April 10, at 5:00 p.m. The Court intends to resolve the emergency motion before the end of the week. Ordered by Judge Stephanos Bibas on 4/8/2024. (mpb) (Entered: 04/08/2024) (0) |
| Apr 8, 2024 | 212 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 202 Notice of Appeal (Federal Circuit) filed by Galderma Laboratories L.P., TCD Royalty Sub LP. USCA Case Number 2024-1664 (mpb) (Entered: 04/08/2024) (4) |
| Apr 5, 2024 | 207 | [SEALED] ANSWERING BRIEF in Opposition re 203 Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion filed by Lupin Inc., Lupin Limited.Reply Brief due date per Local Rules is 4/12/2024. (Phillips, John) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | 208 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding objections to disclosure of Lupin's expert. (Phillips, John) (Entered: 04/05/2024) (0) |
| Apr 4, 2024 | 203 | Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 04/04/2024) (8) |
| Apr 4, 2024 | 204 | [SEALED] OPENING BRIEF in Support re 203 Emergency MOTION for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of This Motion filed by Galderma Laboratories L.P., TCD Royalty Sub LP.Answering Brief/Response due date per Local Rules is 4/18/2024. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) (Entered: 04/04/2024) (0) |
| Apr 4, 2024 | 205 | [SEALED] DECLARATION re 204 Opening Brief in Support, -- Declaration of Andrew J. Cochran -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits A-K)(Tigan, Jeremy) (Entered: 04/04/2024) (0) |
| Apr 4, 2024 | 206 | NOTICE of Lodging by Galderma Laboratories L.P., TCD Royalty Sub LP re 205 Declaration (Tigan, Jeremy) (Entered: 04/04/2024) (2) |
| Apr 2, 2024 | 202 | Notice of Appeal* (1) |
| Apr 1, 2024 | 200 | JUDGMENT in favor of Lupin Inc., Lupin Limited against Galderma Laboratories L.P., TCD Royalty Sub LP for specific claims and counterclaims. All claims of infringement of any claims of the '532 patent or '740 patent notexpressly enumerated above are dismissed with prejudice. See Judgment for further details. (CASE CLOSED.) Signed by Judge Stephanos Bibas on 04/01/2024. (vfm) (Entered: 04/01/2024) (3) |
| Apr 1, 2024 | 201 | Final Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (vfm) (Entered: 04/01/2024) (2) |
| Mar 29, 2024 | 199 | Joint Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Status Report - re 198 Order, Set Deadlines. (Attachments: # 1 Exhibit A - Proposed Final Judgment)(Tigan, Jeremy) (Entered: 03/29/2024) (0) |
| Mar 22, 2024 | 197 | [UNSEALED] MEMORANDUM OPINION Signed by Judge Stephanos Bibas on 3/22/2024.This order has been emailed to local counsel. (mpb) (Entered: 03/22/2024) (20) |
| Mar 22, 2024 | 198 | [UNSEALED] ORDER Setting Deadlines: ( Notice of Compliance deadline set for 3/31/2024.) Signed by Judge Stephanos Bibas on 3/22/2024.This order has been emailed to local counsel. (mpb) (Entered: 03/22/2024) (1) |
| Feb 28, 2024 | 194 | Official Transcript of a Bench Trial Morning Session held on 01/9/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Bobbie J. Shanfelder,Email: Bobbie_Shanfelder@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/20/2024. Redacted Transcript Deadline set for 4/1/2024. Release of Transcript Restriction set for 5/28/2024. (apk) (Entered: 02/28/2024) (164) |
| Feb 28, 2024 | 195 | Official Transcript of Bench Trial Morning Session held on 01/10/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Bobbie J. Shanfelder,Email: Bobbie_Shanfelder@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/20/2024. Redacted Transcript Deadline set for 4/1/2024. Release of Transcript Restriction set for 5/28/2024. (apk) (Entered: 02/28/2024) (131) |
| Feb 28, 2024 | 196 | Official Transcript of Bench Trial Morning Session held on 01/11/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Bobbie J. Shanfelder,Email: Bobbie_Shanfelder@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/20/2024. Redacted Transcript Deadline set for 4/1/2024. Release of Transcript Restriction set for 5/28/2024. (apk) (Entered: 02/28/2024) (66) |
| Feb 26, 2024 | 193 | Official Transcript of Civil Bench Trial Day Four Closing Statements held on 02/22/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Bobbie J. Shanfelder, Email: Bobbie_Shanfelder@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/18/2024. Redacted Transcript Deadline set for 3/28/2024. Release of Transcript Restriction set for 5/28/2024. (vfm) (Entered: 02/26/2024) (69) |
| Feb 20, 2024 | 187 | REDACTED VERSION of 177 POST Trial Brief by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 02/20/2024) (30) |
| Feb 20, 2024 | 188 | REDACTED VERSION of 178 Proposed Findings of Fact by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 02/20/2024) (30) |
| Feb 20, 2024 | 189 | REDACTED VERSION of 179 Appendix by Lupin Inc., Lupin Limited. (Attachments: # 1 A901-A1223)(Haney, Megan) (Main Document 189 replaced on 2/21/2024) (vfm). (Attachment 1 replaced on 2/21/2024) (vfm). (Entered: 02/20/2024) (0) |
| Feb 20, 2024 | 190 | REDACTED VERSION of 180 Appendix by Lupin Inc., Lupin Limited. (Attachments: # 1 A1224-A1500)(Haney, Megan) (Entered: 02/20/2024) (0) |
| Feb 20, 2024 | 191 | REDACTED VERSION of 183 Appendix, by Lupin Inc., Lupin Limited. (Attachments: # 1 A300-A600, # 2 A601-A922, # 3 A923-A1223)(Haney, Megan) (Entered: 02/20/2024) (0) |
| Feb 20, 2024 | 192 | REDACTED VERSION of 184 Appendix, by Lupin Inc., Lupin Limited. (Attachments: # 1 A1224-A1500, # 2 A1501-A1883, # 3 A1884-A2003, # 4 A2004-A2200, # 5 A2201-A2483)(Haney, Megan) (Entered: 02/20/2024) (0) |
| Feb 16, 2024 | 185 | POST TRIAL BRIEF Defendants Lupin Inc. and Lupin Limited's Responsive Post-Trial Brief by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 02/16/2024) (20) |
| Feb 16, 2024 | 186 | POST TRIAL BRIEF -- Plaintiffs' Responsive Post-Trial Brief -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 02/16/2024) (26) |
| Feb 15, 2024 | 183 | [SEALED] APPENDIX re 179 Appendix, 178 Proposed Findings of Fact, 177 POST Trial Brief [Corrected] by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A1-A300, # 2 Exhibit A301-A600, # 3 Exhibit A601-A900, # 4 Exhibit A901-A1223)(Haney, Megan) (Entered: 02/15/2024) (0) |
| Feb 15, 2024 | 184 | [SEALED] APPENDIX re 180 Appendix, 178 Proposed Findings of Fact, 177 POST Trial Brief [Corrected] (Vol. 2 of 2) by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A1224-A1500, # 2 Exhibit A1501-A1800, # 3 Exhibit A1801-A2000, # 4 Exhibit A2001-A2200, # 5 Exhibit A2201-A2483)(Haney, Megan) (Entered: 02/15/2024) (0) |
| Feb 12, 2024 | 182 | STIPULATION AND ORDER regarding D.I. 181 . The time for Lupin to file redacted versions of its post-trial submissions (D.I. 177 , 178 , 179 , and 180 ) is extended to February 20, 2024. (Notice of Compliance deadline set for 2/20/2024) Signed by Judge Stephanos Bibas on 2/12/2024. (apk) (Entered: 02/12/2024) (2) |
| Feb 9, 2024 | 181 | STIPULATION TO EXTEND TIME for Lupin to file redacted versions of its post-trial submissions (D.I. 177, 178, 179 and 180) to February 20, 2024 - filed by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 02/09/2024) (2) |
| Feb 2, 2024 | 174 | POST TRIAL BRIEF -- Plaintiffs' Opening Post-Trial Brief -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 02/02/2024) (30) |
| Feb 2, 2024 | 175 | Proposed Findings of Fact by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Main Document 175 replaced on 2/16/2024) (smg). (Entered: 02/02/2024) (30) |
| Feb 2, 2024 | 176 | APPENDIX re 175 Proposed Findings of Fact by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Main Document 176 replaced on 2/16/2024) (smg). (Entered: 02/02/2024) (4) |
| Feb 2, 2024 | 177 | [SEALED] POST TRIAL BRIEF Defendants Lupin Inc. and Lupin Limited's Opening Post-Trial Brief by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 178 | [SEALED] Proposed Findings of Fact by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 179 | [SEALED] APPENDIX re 178 Proposed Findings of Fact, 177 POST Trial Brief Volume 1 of 2 by Lupin Inc., Lupin Limited. (Attachments: # 1 A901-1223)(Phillips, John) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 180 | [SEALED] APPENDIX re 178 Proposed Findings of Fact, 177 POST Trial Brief Volume 2 of 2 by Lupin Inc., Lupin Limited. (Attachments: # 1 A1224-1500)(Phillips, John) (Entered: 02/02/2024) (0) |
| Jan 30, 2024 | 171 | Official Transcript of Bench Trial held on 1/9/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Kim L. Haley,Email: Kim_Haley@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 2/20/2024. Redacted Transcript Deadline set for 3/1/2024. Release of Transcript Restriction set for 4/29/2024. (mpb) (Entered: 01/30/2024) (158) |
| Jan 30, 2024 | 172 | Official Transcript of Bench Trial held on 1/10/24 before Judge Stephanos Bibas. Court Reporter/Transcriber Kim L. Haley,Email: Kim_Haley@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 2/20/2024. Redacted Transcript Deadline set for 3/1/2024. Release of Transcript Restriction set for 4/29/2024. (mpb) (Entered: 01/30/2024) (157) |
| Jan 30, 2024 | 173 | Official Transcript of Bench Trial held on 1/11/2024 before Judge Stephanos Bibas. Court Reporter/Transcriber Kim L. Haley,Email: Kim_Haley@paed.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 2/20/2024. Redacted Transcript Deadline set for 3/1/2024. Release of Transcript Restriction set for 4/29/2024. (mpb) (Entered: 01/30/2024) (22) |
| Dec 18, 2023 | 170 | Amended EXHIBIT re 156 Proposed Pretrial Order, --Amended Exhibits 12 and 13-- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit 12, # 2 Exhibit 13)(Tigan, Jeremy) (Entered: 12/18/2023) (0) |
| Nov 20, 2023 | 169 | ORAL ORDER, I DENY Lupin's motions in limine (D.I. 156-14, D.I. 156-15). But Lupin may raise these objections again at trial. Ordered by Judge Stephanos Bibas on 11/20/2023. (twk) (Entered: 11/20/2023) (0) |
| Nov 16, 2023 | 168 | REDACTED VERSION of 163 Answering Brief in Opposition, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 11/16/2023) (4) |
| Nov 15, 2023 | 167 | Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs asserted claims for trial - re 156 Proposed Pretrial Order,. (Tigan, Jeremy) (Entered: 11/15/2023) (1) |
| Nov 13, 2023 | 165 | ORAL ORDER, I DENY the motion seeking leave to file a sur-reply (D.I. 162 ). Trial remains scheduled to start on Tuesday, January 9, 2024, and will not last longer than four days; trial days will be as long as needed to finish the trial within that time. Signed by Judge Stephanos Bibas on 11/13/23. (rlr) (Entered: 11/13/2023) (0) |
| Nov 13, 2023 | 166 | ORAL ORDER, I DENY Lupins limited motion to preclude (D.I. 153 ). But Lupin may raise this objection again at trial should it choose to do so. Signed by Judge Stephanos Bibas on 11/13/23. (rlr) (Entered: 11/13/2023) (0) |
| Nov 10, 2023 | 163 | [SEALED] ANSWERING BRIEF in Opposition re 162 MOTION for Leave to File a Sur-Reply in Further Opposition to Defendants' Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations filed by Lupin Inc., Lupin Limited.Reply Brief due date per Local Rules is 11/17/2023. (Phillips, John) (Entered: 11/10/2023) (0) |
| Nov 10, 2023 | 164 | REDACTED VERSION of 157 Reply Brief, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 11/10/2023) (14) |
| Nov 9, 2023 | 161 | SO ORDERED, regarding D.I. 160 Stipulation and Proposed Order Regarding Ownership and Standing. Signed by Judge Stephanos Bibas on 11/9/2023. (apk) (Entered: 11/09/2023) (0) |
| Nov 9, 2023 | 162 | MOTION for Leave to File a Sur-Reply in Further Opposition to Defendants' Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 11/09/2023) (0) |
| Nov 8, 2023 | 160 | STIPULATION and [Proposed] Order Regarding Ownership and Standing by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/08/2023) (2) |
| Nov 3, 2023 | 157 | [SEALED] REPLY BRIEF re 153 MOTION Defendants Lupin Inc. and Lupin Limited's Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations and Memorandum in Support Thereof filed by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 11/03/2023) (0) |
| Nov 3, 2023 | 158 | REDACTED VERSION of 155 Answering Brief in Opposition, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 11/03/2023) (0) |
| Nov 3, 2023 | 159 | REDACTED VERSION of 156 Proposed Pretrial Order, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Ex. 1, # 2 Ex. 2, # 3 Ex. 3, # 4 Ex. 4, # 5 Ex. 5, # 6 Ex. 6, # 7 Ex. 7, # 8 Ex. 8, # 9 Ex. 9, # 10 Ex. 10, # 11 Ex. 11, # 12 Ex. 12, # 13 Ex. 13, # 14 Ex. 14, # 15 Ex. 15)(Tigan, Jeremy) (Entered: 11/03/2023) (0) |
| Oct 27, 2023 | 155 | [SEALED] ANSWERING BRIEF in Opposition re 153 MOTION Defendants Lupin Inc. and Lupin Limited's Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations and Memorandum in Support Thereof filed by Galderma Laboratories L.P., TCD Royalty Sub LP.Reply Brief due date per Local Rules is 11/3/2023. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 10/27/2023) (0) |
| Oct 27, 2023 | 156 | [SEALED] Proposed Pretrial Order by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Tigan, Jeremy) (Entered: 10/27/2023) (0) |
| Oct 20, 2023 | 154 | REDACTED VERSION of 153 MOTION Defendants Lupin Inc. and Lupin Limited's Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations and Memorandum in Support Thereof by Lupin Inc., Lupin Limited. (Attachments: # 1 7.1.1 Statement, # 2 Proposed Order, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibits 3-9, # 6 Exhibit 10, # 7 Exhibit 11, # 8 Exhibit 12, # 9 Exhibit 13)(Phillips, John) (Entered: 10/20/2023) (0) |
| Oct 13, 2023 | 153 | [SEALED] MOTION Defendants Lupin Inc. and Lupin Limited's Daubert Motion to Preclude Dr. Rudnic's Theory of Lupin's Composition Ratio Based on Day 1 Plasma Concentrations and Memorandum in Support Thereof - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Proposed Order, # 2 Rule 7.1.1 Statement, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13)(Phillips, John) (Entered: 10/13/2023) (0) |
| Oct 10, 2023 | 152 | ORAL ORDER, I DENY Galderma's motion to strike portions of Lupin's expert reports relating to invalidity. (D.I. 123 ). But I remind Lupin that this is an infringement case, not an invalidity case. D.I. 110 , at 21:2021. I also DENY Galderma's motion to strike portions and exhibits of Lupin's expert reports pursuant to Federal Rules of Civil Procedure 16(f) and 37(c)(1). (D.I. 125 ). Ordered by Judge Stephanos Bibas on 10/10/2023. (twk) (Entered: 10/10/2023) (0) |
| Oct 5, 2023 | 151 | SO ORDERED, regarding D.I. 148 MOTION for Pro Hac Vice Appearance of Attorney Katie A. Boda. Signed by Judge Stephanos Bibas on 10/5/2023. (apk) (Entered: 10/05/2023) (0) |
| Oct 4, 2023 | 149 | NOTICE to Take Deposition of Graham Buckton, Ph.D. on October 10, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 10/04/2023) (3) |
| Oct 4, 2023 | 150 | NOTICE to Take Deposition of Vivian Gray on October 12, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 10/04/2023) (3) |
| Oct 3, 2023 | 148 | MOTION for Pro Hac Vice Appearance of Attorney Katie A. Boda - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Certification of Katie A. Boda)(Haney, Megan) (Entered: 10/03/2023) (0) |
| Sep 28, 2023 | 147 | ORAL ORDER: I DENY the parties' stipulation to extend the time to file a joint proposed pretrial order (D.I. 146 ). As I said previously, I will not look kindly on further requests for extensions and require good cause to justify any such requests. Signed by Judge Stephanos Bibas on 9/28/2023. (apk) (Entered: 09/28/2023) (0) |
| Sep 26, 2023 | 146 | STIPULATION TO EXTEND TIME for the parties to file a joint proposed final pretrial order to November 8, 2023 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 09/26/2023) (2) |
| Aug 25, 2023 | 145 | NOTICE to Take Deposition of Edward M. Rudnic, Ph.D. on September 1, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 08/25/2023) (2) |
| Aug 21, 2023 | 144 | SO ORDERED, re 143 STIPULATION TO EXTEND TIME for: (1) Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP to depose the experts of Defendants Lupin Inc. and Lupin Limited, Dr. Graham Buckton and Ms. Vivian Gray, to October 10, 2023, and October 12, 2023, resp filed by Galderma Laboratories L.P., TCD Royalty Sub LP. Signed by Judge Stephanos Bibas on 08/21/2023. (smg) (Entered: 08/21/2023) (2) |
| Aug 18, 2023 | 143 | STIPULATION TO EXTEND TIME for: (1) Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP to depose the experts of Defendants Lupin Inc. and Lupin Limited, Dr. Graham Buckton and Ms. Vivian Gray, to October 10, 2023, and October 12, 2023, respectively; and (2) for Defendants to depose Plaintiffs' expert, Dr. Edward Rudnic, to September 1, 2023 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 08/18/2023) (2) |
| Aug 16, 2023 | 142 | NOTICE OF SERVICE of Reply Expert Report of Edward M. Rudnic, Ph.D. filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 08/16/2023) (3) |
| Aug 9, 2023 | 140 | SO ORDERED, regarding D.I. 139 Unopposed MOTION for Leave to File a Letter Regarding Supplemental Authority. Signed by Judge Stephanos Bibas on 8/9/2023. (apk) (Entered: 08/09/2023) (0) |
| Aug 9, 2023 | 141 | Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Lupin's Motion for Leave - re 139 Unopposed MOTION for Leave to File a Letter Regarding Supplemental Authority . (Tigan, Jeremy) (Entered: 08/09/2023) (2) |
| Aug 8, 2023 | 139 | Unopposed MOTION for Leave to File a Letter Regarding Supplemental Authority - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A, # 2 Proposed Order)(Phillips, John) (Entered: 08/08/2023) (0) |
| Aug 3, 2023 | 137 | REDACTED VERSION of 129 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Phillips, John) (Entered: 08/03/2023) (0) |
| Aug 3, 2023 | 138 | REDACTED VERSION of 130 Letter,,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19)(Phillips, John) (Entered: 08/03/2023) (0) |
| Aug 1, 2023 | 135 | REDACTED VERSION of 126 Letter, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exs. A-I)(Tigan, Jeremy) (Entered: 08/01/2023) (0) |
| Aug 1, 2023 | 136 | REDACTED VERSION of 127 Exhibit to a Document,, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 08/01/2023) (0) |
| Jul 31, 2023 | 132 | Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Reply Letter Brief in Support of Motion to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray - re 123 MOTION to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray. (Tigan, Jeremy) (Entered: 07/31/2023) (3) |
| Jul 31, 2023 | 133 | Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Reply Letter Brief in Support of Motion to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1) - re 125 MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1). (Tigan, Jeremy) (Entered: 07/31/2023) (3) |
| Jul 31, 2023 | 134 | Joint Letter to The Honorable Stephanos Bibas regarding Request for Teleconference - re 125 MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1), 123 MOTION to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray. (Tigan, Jeremy) (Entered: 07/31/2023) (1) |
| Jul 28, 2023 | 131 | SO ORDERED, regarding D.I. 128 ( Notice of Compliance deadline set for 8/1/2023.). Signed by Judge Stephanos Bibas on 7/28/2023. (apk) (Entered: 07/28/2023) (0) |
| Jul 27, 2023 | 128 | STIPULATION TO EXTEND TIME for Plaintiffs to file redacted versions of their Opening Letter Brief in Support of their Motion to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1) (D.I. 126) and Expert Reports Subject to Motions to Strike (D.I. 127) to August 1, 2023 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 07/27/2023) (2) |
| Jul 27, 2023 | 129 | [SEALED] Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Responsive Letter in Opposition to Plaintiffs' Motion to Strike Invalidity Proffers (D.I. 123). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Phillips, John) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 130 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Opposition to Plaintiffs' Motion to Strike Rebuttal Expert Opinions and Evidence - re 125 MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19)(Phillips, John) (Attachment 1 replaced on 7/31/2023) (apk). (Entered: 07/27/2023) (0) |
| Jul 20, 2023 | 123 | MOTION to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 07/20/2023) (4) |
| Jul 20, 2023 | 124 | Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan - re 123 MOTION to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 07/20/2023) (0) |
| Jul 20, 2023 | 125 | MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1) - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 07/20/2023) (5) |
| Jul 20, 2023 | 126 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan - re 125 MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1). (Attachments: # 1 Exhibits A-I)(Tigan, Jeremy) (Entered: 07/20/2023) (0) |
| Jul 20, 2023 | 127 | [SEALED] EXHIBIT re 125 MOTION to Strike Certain Portions and Exhibits from the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray Pursuant to Fed. R. Civ. P. 16(f) and 37(c)(1), 126 Letter, 124 Letter, 123 MOTION to Strike Portions of the Rebuttal Expert Reports of Graham Buckton, Ph.D. and Vivian Gray -- Expert Reports Subject to Motions to Strike -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibit A - Rebuttal Expert Report of Graham Buckton, Ph.D., # 2 Exhibit B - Rebuttal Expert Report of Vivian Gray)(Tigan, Jeremy) (Entered: 07/20/2023) (0) |
| Jul 12, 2023 | 122 | NOTICE OF SERVICE of Rebuttal Expert Report of Graham Buckton, Ph.D. and Rebuttal Expert Report of Vivian Gray filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 07/12/2023) (2) |
| Jun 8, 2023 | 121 | NOTICE OF SERVICE of Opening Expert Report of Edward M. Rudnic, Ph.D. Regarding Lupin's Infringement of U.S. Patent Nos. 7,749,532 and 8,206,740 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 06/08/2023) (3) |
| May 26, 2023 | 120 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 05/26/2023) (3) |
| May 12, 2023 | 119 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Third Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 05/12/2023) (3) |
| May 11, 2023 | 117 | NOTICE OF SERVICE of Lupin's Supplemental Responses and Objections to Plaintiffs' Request for Production No. 134 and Lupin's Supplemental Responses and Objections to Plaintiffs' Interrogatories (Nos. 1-2) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 05/11/2023) (2) |
| May 11, 2023 | 118 | SO ORDERED, re 116 STIPULATION of Dismissal and [Proposed] Order of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478. Ordered by Judge Stephanos Bibas on 05/11/2023. (smg) (Entered: 05/11/2023) (0) |
| May 10, 2023 | 116 | STIPULATION of Dismissal and [Proposed] Order of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478 by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 05/10/2023) (4) |
| May 9, 2023 | 115 | NOTICE to Take Deposition of Liza Dahm on May 12, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 05/09/2023) (2) |
| May 3, 2023 | 113 | SO ORDERED, re 112 STIPULATION TO EXTEND TIME for the parties (1) to serve opening expert reports; (2) to serve rebuttal expert reports; and (3) to serve reply expert reports to June 7, 2023; July 12, 2023; and August 16, 2023. Ordered by Judge Stephanos Bibas on 5/3/2023. (twk) (Entered: 05/03/2023) (0) |
| May 3, 2023 | 114 | ORAL ORDER, The scheduling order (D.I. 18 ) is modified as follows: The Court will hold a pretrial conference by Zoom at 10 a.m. eastern time on November 15, 2023. Trial will begin on January 9, 2024, in courtroom 4-B of the Byrne courthouse in Philadelphia. Ordered by Judge Stephanos Bibas on 5/3/2023. (twk) (Entered: 05/03/2023) (0) |
| May 2, 2023 | 112 | STIPULATION TO EXTEND TIME for the parties (1) to serve opening expert reports; (2) to serve rebuttal expert reports; and (3) to serve reply expert reports to June 7, 2023; July 12, 2023; and August 16, 2023 - filed by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 05/02/2023) (2) |
| Apr 27, 2023 | 111 | NOTICE to Take Deposition of Sean Griffin on April 28, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 04/27/2023) (2) |
| Apr 11, 2023 | 110 | Official Transcript of Telephone Conference held on 03/30/2023 before Judge Bibas. Court Reporter/Transcriber Brian Gaffigan,Email: gaffigan.b@outlook.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 5/2/2023. Redacted Transcript Deadline set for 5/12/2023. Release of Transcript Restriction set for 7/10/2023. (smg) (Entered: 04/11/2023) (0) |
| Apr 7, 2023 | 108 | MEMORANDUM OPINION. Signed by Judge Stephanos Bibas on 04/07/2023. (smg) (Entered: 04/10/2023) (10) |
| Apr 7, 2023 | 109 | ORDER Regarding Terms of US Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; and 8,709,478. (See Order for additional details) Signed by Judge Stephanos Bibas on 04/07/2023. (smg) (Entered: 04/10/2023) (1) |
| Apr 6, 2023 | 107 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Fifth Set of Interrogatories (Nos. 22-25) and (2) Plaintiffs' Objections and Responses to Defendants' Fifth Set of Requests for Production (Nos. 20-33) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/06/2023) (3) |
| Apr 3, 2023 | 105 | NOTICE to Take Deposition of Rajiv Khurana on April 14, 2023 or a mutually agreeable date filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/03/2023) (3) |
| Apr 3, 2023 | 106 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Second Set of Interrogatories (Nos. 8-11) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 04/03/2023) (2) |
| Mar 31, 2023 | 104 | NOTICE OF SERVICE of Plaintiffs' Corrected Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/31/2023) (3) |
| Mar 30, 2023 | 102 | ORAL ORDER, Because defendant has failed to show good cause, I DENY its motion to amend (D.I. 86 ). Signed by Judge Stephanos Bibas on 03/30/2023. (apk) (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 103 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/30/2023) (3) |
| Mar 27, 2023 | 100 | NOTICE to Take Deposition of Pramod Dahibhate on April 5, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/27/2023) (3) |
| Mar 27, 2023 | 101 | REDACTED VERSION of 93 Letter, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 03/27/2023) (4) |
| Mar 24, 2023 | 97 | [SEALED] Transcript of Markman Hearing held on 3/14/2023 before Judge Stephanos Bibas. (nmg) (Entered: 03/24/2023) (0) |
| Mar 24, 2023 | 98 | REDACTED VERSION of 92 Letter, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/24/2023) (Main Document) (5) |
| Mar 24, 2023 | 99 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Lupin Inc. and Lupin Limited's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 98 | REDACTED VERSION of 92 Letter, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/24/2023) (Exhibits 1-8) (30) |
| Mar 21, 2023 | 95 | NOTICE of Subpoena by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 03/21/2023) (Main Document) (1) |
| Mar 21, 2023 | 96 | NOTICE to Take Deposition of Makarand Avachat on March 29, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/21/2023) (3) |
| Mar 21, 2023 | 95 | NOTICE of Subpoena by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 03/21/2023) (Exhibit 1) (4) |
| Mar 20, 2023 | 93 | [SEALED] Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Reply in Support of Defendants' Motion for Leave to Amend Answer and Counterclaims - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Phillips, John) (Entered: 03/20/2023) (0) |
| Mar 20, 2023 | 94 | Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding request for a teleconference on Lupin's Motion for Leave to Amend Answer and Counterclaims (D.I. 86). (Phillips, John) (Entered: 03/20/2023) (1) |
| Mar 17, 2023 | 92 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Opposition to Lupin's Motion for Leave to Amend Answer and Counterclaims - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/17/2023) (0) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Main Document) (5) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 1) (26) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 2) (26) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibits 3-6) (1) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 7) (5) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibits 8-12) (1) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 13) (13) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 14) (4) |
| Mar 15, 2023 | 90 | STIPULATION TO EXTEND TIME for Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP to respond to Defendants Lupin Inc. and Lupin Limited's Motion for Leave to Amend Answer and Counterclaims (D.I. 86) to March 17, 2023 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 03/15/2023) (1) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Main Document) (1) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Exhibit 1) (27) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Exhibit 2) (27) |
| Mar 10, 2023 | 88 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Third Set of Interrogatories (Nos. 11-16) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/10/2023) (3) |
| Mar 9, 2023 | 86 | MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 03/09/2023) (Main Document) (1) |
| Mar 9, 2023 | 87 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Opening Letter Brief in Support of Motion for Leave to Amend - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Phillips, John) (Main Document 87 replaced on 3/21/2023) (mkr). (Entered: 03/09/2023) (0) |
| Mar 9, 2023 | 86 | MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 03/09/2023) (Text of Proposed Order) (1) |
| Mar 7, 2023 | 85 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Fifth Set of Interrogatories to Plaintiffs (Nos. 22-25) and Lupin Inc. and Lupin Limited's Fifth Set of Requests for Production (Nos. 20-33) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 03/07/2023) (2) |
| Mar 3, 2023 | 84 | NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Interrogatories to Lupin Inc. and Lupin Limited (Nos. 8-11); (2) Plaintiffs' First Supplemental Objections and Responses to Defendants' Third Set of Requests for Production (Nos. 14-17); and (3) Plaintiffs' Second Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/03/2023) (3) |
| Feb 28, 2023 | 80 | NOTICE to Take Deposition of Arash Raoufinia Pursuant to Rule 30(b)(1) on March 24, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/28/2023) (2) |
| Feb 28, 2023 | 81 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Notice of Deposition of Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) and Lupin Inc. and Lupin Limited's Fourth Set of Interrogatories to Plaintiffs (Nos. 17-21) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/28/2023) (2) |
| Feb 28, 2023 | 82 | NOTICE to Take Deposition of Rajiv Khurana on March 16, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/28/2023) (3) |
| Feb 28, 2023 | 83 | NOTICE to Take Deposition of Sanjay Wagh on March 16, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/28/2023) (3) |
| Feb 23, 2023 | 78 | NOTICE to Take Deposition of Makarand Avachat on March 29, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/23/2023) (3) |
| Feb 23, 2023 | 79 | REDACTED VERSION of 74 Letter by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/23/2023) (Main Document) (1) |
| Feb 23, 2023 | 79 | REDACTED VERSION of 74 Letter by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/23/2023) (Exhibit A) (3) |
| Feb 21, 2023 | 77 | REDACTED VERSION of 73 Letter, to The Honorable Stephanos Bibas from Jeremy A. Tigan by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/21/2023) (Main Document) (4) |
| Feb 21, 2023 | 77 | REDACTED VERSION of 73 Letter, to The Honorable Stephanos Bibas from Jeremy A. Tigan by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/21/2023) (Exhibits 12-21) (30) |
| Feb 17, 2023 | 75 | Letter to The Honorable Stephanos Bibas from Jack B. Blumenfeld regarding motion for summary judgment - re 74 Letter. (Blumenfeld, Jack) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 76 | ORAL ORDER, I DENY Lupin's request for leave to file a motion for summary judgment (D.I. 64 ). Ordered by Judge Stephanos Bibas on 2/17/2023. (twk) (Entered: 02/17/2023) (0) |
| Feb 16, 2023 | 74 | [SEALED] Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Lupin's request for leave to file a reply in support of its motion for leave for summary judgment. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/16/2023) (0) |
| Feb 13, 2023 | 73 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Response to Lupin's Request for Leave to File a Summary Judgment Motion - re 64 Letter,. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/13/2023) (0) |
| Feb 10, 2023 | 72 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs' Fourth Set of Requests for Production (Nos. 132-134) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/10/2023) (2) |
| Feb 8, 2023 | 70 | NOTICE of Change of Firm Affiliation by Galderma Laboratories L.P., TCD Royalty Sub LP (Tigan, Jeremy) (Entered: 02/08/2023) (2) |
| Feb 8, 2023 | 71 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Third Set of Interrogatories to Plaintiffs (Nos. 11-16) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/08/2023) (2) |
| Feb 3, 2023 | 67 | NOTICE requesting Clerk to remove Evan D. Diamond, Vanessa Y. Yen, and the law firm of King & Spalding LLP as co-counsel.. (Tigan, Jeremy) (Entered: 02/03/2023) (2) |
| Feb 3, 2023 | 68 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 6-10); (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Admission (Nos. 20-23); and (3) Plaintiffs' First Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/03/2023) (3) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Main Document) (4) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 1) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 2) (11) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 3) (8) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 4-7) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 8) (2) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 9) (9) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 10) (21) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 11) (16) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Proposed Order) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (7.1.1 Statement) (1) |
| Jan 30, 2023 | 65 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Fourth Set of Requests for Production (Nos. 18-19) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/30/2023) (3) |
| Jan 30, 2023 | 66 | ORAL ORDER, Plaintiffs shall respond in writing to Defendants' request to file a motion for summary judgment (D.I. 64 ) no later than February 13, 2023 (Notice of Compliance deadline set for 2/13/2023.) Signed by Judge Stephanos Bibas on 1/30/2023. (apk) (Entered: 01/30/2023) (0) |
| Jan 27, 2023 | 64 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Lupin's Request for Leave to File a Summary Judgment Motion. (Attachments: # 1 Exhibit 1 (Part 1/2), # 2 Exhibit 1 (Part 2/2), # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Text of Proposed Order, # 14 D. Del. LR 7.1.1 Statement)(Phillips, John) (Entered: 01/27/2023) (0) |
| Jan 18, 2023 | 63 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Third Set of Requests for Production (Nos. 14-17) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/18/2023) (3) |
| Jan 13, 2023 | 62 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 01/13/2023) (2) |
| Jan 11, 2023 | 61 | NOTICE OF SERVICE of Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (Nos. 132-134) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/11/2023) (3) |
| Jan 5, 2023 | 60 | NOTICE of Change of Firm Affiliation by Galderma Laboratories L.P., TCD Royalty Sub LP (Blumenfeld, Jack) (Entered: 01/05/2023) (3) |
| Jan 4, 2023 | 59 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Second Set of Interrogatories to Plaintiffs (Nos. 6-10) and Lupin Inc. and Lupin Limited's Second Set of Requests for Admission (Nos. 20-23) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 01/04/2023) (2) |
| Dec 30, 2022 | 58 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Third Set of Requests for Production (No. 131) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/30/2022) (2) |
| Dec 29, 2022 | 57 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Fourth Set of Requests for Production (Nos. 18-19) and Defendants Lupin Inc. and Lupin Limited's Supplemental Responses and Objections to Plaintiffs First Set of Requests for Production (Nos. 1-2) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/29/2022) (2) |
| Dec 23, 2022 | 56 | Interim STATUS REPORT by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 12/23/2022) (3) |
| Dec 20, 2022 | 55 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Third Set of Requests for Production (Nos. 14-17) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/20/2022) (2) |
| Dec 19, 2022 | 54 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Second Set of Requests for Production (Nos. 119-130) and Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-7) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/19/2022) (2) |
| Dec 1, 2022 | 53 | SO ORDERED, regarding D.I. 51 STIPULATION TO EXTEND TIME for the parties to file any motions to join other parties, and to amend or supplement the pleadings pursuant to paragraph 3 of the Scheduling Order (D.I. 18 ) to December 7, 2022 filed by Lupin Inc., Lupin Limited. Signed by Judge Stephanos Bibas on 12/1/2022. (apk) (Entered: 12/01/2022) (0) |
| Nov 30, 2022 | 51 | STIPULATION TO EXTEND TIME for the parties to file any motions to join other parties, and to amend or supplement the pleadings pursuant to paragraph 3 of the Scheduling Order (D.I. 18) to December 7, 2022 - filed by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 11/30/2022) (2) |
| Nov 30, 2022 | 52 | NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (No. 131) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/30/2022) (3) |
| Nov 28, 2022 | 48 | REDACTED VERSION of 45 Joint Claim Construction Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exs. A-G)(Tigan, Jeremy) (Entered: 11/28/2022) (Main Document) (30) |
| Nov 28, 2022 | 49 | [SEALED] STATEMENT -- Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP's Comments on Defendants Lupin Inc. and Lupin Limited's Claim Construction Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/28/2022) (0) |
| Nov 28, 2022 | 50 | STATEMENT Lupin's Comments on Plaintiffs' Technology Tutorial by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 11/28/2022) (4) |
| Nov 28, 2022 | 48 | REDACTED VERSION of 45 Joint Claim Construction Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exs. A-G)(Tigan, Jeremy) (Entered: 11/28/2022) (Exs. A-G) (30) |
| Nov 21, 2022 | 45 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits A-G)(Tigan, Jeremy) (Entered: 11/21/2022) (0) |
| Nov 21, 2022 | 46 | STATEMENT -- Plaintiffs' Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/21/2022) (20) |
| Nov 21, 2022 | 47 | STATEMENT -- Lupin's Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/21/2022) (19) |
| Nov 18, 2022 | 44 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Lupin Inc. and Lupin Limited (Nos. 1-7); (2) Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 119-130); and (3) Plaintiffs' Notice of Deposition of Lupin Pursuant to Fed. R. Civ P. 30(b)(6) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/18/2022) (3) |
| Nov 16, 2022 | 43 | NOTICE OF SERVICE of Joint Claim Construction Brief Containing Lupin's Sur-Reply Brief filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 11/16/2022) (2) |
| Nov 14, 2022 | 42 | NOTICE OF SERVICE of Lupin's Technology Tutorial filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 11/14/2022) (2) |
| Nov 4, 2022 | 41 | NOTICE OF SERVICE of Plaintiffs' Technology Tutorial filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/04/2022) (3) |
| Oct 28, 2022 | 40 | NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 10/28/2022) (3) |
| Oct 14, 2022 | 38 | Joint Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Claim Construction Hearing. (Tigan, Jeremy) (Entered: 10/14/2022) (1) |
| Oct 14, 2022 | 39 | NOTICE OF SERVICE of Lupin's Answering Claim Construction Brief filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 10/14/2022) (2) |
| Sep 29, 2022 | 37 | ORAL ORDER, Plaintiffs have asked me to change tutorial deadlines D.I. 36 . Defendants have not weighed in. I therefore modify the scheduling order as follows: The parties joint or separate claim construction technology tutorials are due on November 21, 2022. Each party may comment in writing (in no more than five pages) on the opposing partys tutorial no later than November 28, 2022. Signed by Judge Stephanos Bibas on 9/29/2022. (apk) (Entered: 09/29/2022) (0) |
| Sep 23, 2022 | 35 | NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 09/23/2022) (3) |
| Sep 23, 2022 | 36 | MOTION to Modify the Scheduling Order re 18 Scheduling Order,, Set Deadlines/Hearings, - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 09/23/2022) (3) |
| Sep 2, 2022 | 33 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Production (Nos. 8-13) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Main Document) (13) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 1-14) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 15-21) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 22) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 1 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 2 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 3 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 4 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 5 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 6 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 7 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 24-25) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 26-27) (30) |
| Aug 29, 2022 | 32 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-5) and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-19) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 08/29/2022) (3) |
| Aug 22, 2022 | 31 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms and Phrases for Construction and Proposed Constructions filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 08/22/2022) (3) |
| Aug 3, 2022 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Second Set of Requests for Production (Nos. 8-13) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| Jul 29, 2022 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Request for Production of Documents and Things (Nos. 1-7) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jul 29, 2022 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-5); Lupin Inc. and Lupin Limited's First Set of Requests for Admission (Nos. 1-19) and Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs First Set of Requests for Production (Nos. 1-118) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| Jul 22, 2022 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jun 29, 2022 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jun 29, 2022 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's First Set of Requests for Production filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 24, 2022 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Parties' Proposed ESI Order filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| May 24, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Initial Disclosures Pursuant to Paragraph 3 of the Stipulated Order Regarding Discovery filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 23, 2022 | 22 | Stipulation and Order (11) Docket Text: STIPULATED ORDER re [19] [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"). Signed by Judge Stephanos Bibas on 5/23/2022. (nmg) |
| May 20, 2022 | 19 | Proposed Order (11) Docket Text: PROPOSED ORDER -- [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| May 20, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 20, 2022 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| May 19, 2022 | 18 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties and Amendment of Pleadings due by 11/30/2022. Fact Discovery completed by 4/7/2023. Opening Expert Reports due by 6/2/2023. Rebuttal Expert Reports due by 8/11/2023. Joint Claim Construction Brief due by 11/21/2022. (See Order for further Deadlines and Hearings). Signed by Judge Stephanos Bibas on 5/19/2022. (twk) |
| May 18, 2022 | 17 | Main Document (1) Docket Text: Letter to The Honorable Stephanos Bibas from Megan C. Haney regarding Chart with Competing Date Proposals for Rule 16 Hearing. (Attachments: # (1) Exhibit A)(Haney, Megan) |
| May 18, 2022 | 17 | Exhibit A (3) |
| May 11, 2022 | 16 | Main Document (1) Docket Text: Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Request for Scheduling Conference. (Attachments: # (1) Proposed Scheduling Order)(Phillips, John) |
| May 11, 2022 | 16 | Proposed Scheduling Order (13) |
| Apr 28, 2022 | 15 | Protective Order (19) Docket Text: PROTECTIVE ORDER. Signed by Judge Stephanos Bibas on 4/28/2022. (cna, ) |
| Apr 27, 2022 | 14 | Proposed Order (19) Docket Text: PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Mar 22, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Vanessa Y. Yen and Evan D. Diamond for Galderma Laboratories L.P., and TCD Royalty Sub LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 18, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Stephanos Bibas, of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
| Mar 18, 2022 | 13 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 3/18/2022. (rjb) |
| Mar 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew J. Cochran and Gerald J. Flattmann, Jr for Galderma Laboratories L.P. and TCD Royalty Sub LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Feb 28, 2022 | 12 | Answer to Counterclaim (9) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Galderma Laboratories L.P., TCD Royalty Sub LP.(Blumenfeld, Jack) |
| Feb 7, 2022 | 10 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, with Jury Demand Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Limited, Lupin Inc..(Phillips, John) |
| Feb 7, 2022 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Inc. filed by Lupin Inc., Lupin Limited. (Phillips, John) |
| Jan 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran filed by Galderma Laboratories L.P., TCD Royalty Sub LP. Signed by Judge Leonard P. Stark on 1/24/22. (ntl) |
| Jan 24, 2022 | 9 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Blumenfeld, Jack) |
| Jan 12, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Joseph T. Jaros, Natasha L. White, Adrianne C. Rose, and William A. Rakoczy for Lupin Inc. and Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Jan 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Natasha L. White and Adrianne C. Rose filed by Lupin Inc., Lupin Limited. Signed by Judge Leonard P. Stark on 1/11/22. (ntl) |
| Jan 11, 2022 | 8 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Natasha L. White and Adrianne C. Rose - filed by Lupin Inc., Lupin Limited. (Attachments: # (1) Certification of William A. Rakoczy, # (2) Certification of Joseph T. Jaros, # (3) Certification of Natasha L. White, # (4) Certification of Adrianne C. Rose)(Haney, Megan) |
| Jan 11, 2022 | 8 | Certification of William A. Rakoczy (1) |
| Jan 11, 2022 | 8 | Certification of Joseph T. Jaros (1) |
| Jan 11, 2022 | 8 | Certification of Natasha L. White (1) |
| Jan 11, 2022 | 8 | Certification of Adrianne C. Rose (1) |
| Dec 9, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by TCD Royalty Sub LP, Galderma Laboratories L.P.: For Lupin Inc. waiver sent on 12/7/2021, answer due 2/7/2022; Lupin Limited waiver sent on 12/7/2021, answer due 2/7/2022. (Blumenfeld, Jack) |
| Dec 8, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 3, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT filed against Lupin Inc., Lupin Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3755546.) - filed by TCD Royalty Sub LP, Galderma Laboratories L.P.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(apk) |
| Dec 3, 2021 | 1 | Exhibit A-F (119) |
| Dec 3, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 3, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Dec 3, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/22/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 4/22/2024. (apk) |
| Dec 3, 2021 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2 ;8,206,740 B2 ;8,394,405 B2 ;8,394,406 B2 ;8,470,364 B2 ;8,709,478 B2. (apk) |
| Dec 3, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Drug Royalty III LP 2, Corporate Parent DRI Healthcare Trust for TCD Royalty Sub LP; Corporate Parent Galderma Services Inc. for Galderma Laboratories L.P. filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (apk) |
| Dec 3, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Inc. on 12/3/2021; Lupin Limited on 12/3/2021. (Attachments: # (1) Summons Issued)(apk) |
| Dec 3, 2021 | 6 | Summons Issued (2) |
| Dec 3, 2021 | 1 | Complaint* (1) |
